PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 14, 2026Journal of Medicinal Chemistry9 citationsOpen Access

Unhooking the Hook: Optimization of the Aurora A Targeting PROTAC JB170 to CCT400028 , an In Vitro Degrader Chemical Probe

View Full Paper
JOJack A. O’HanlonKGKatrin GutscheJMJuliane Elisabeth Müller

Key Points

  • The aim is to optimize the Aurora A targeting PROTAC CCT400028 to overcome limitations linked to PROTACs.
  • Developed a second-generation Aurora A PROTAC derived from alisertib.
  • Optimized the CRBN-targeting warhead to reduce affinity for cereblon.
  • Assessed degradation efficacy in pediatric tumor cell lines.
  • Achieved potent Aurora A degradation in three pediatric tumor cell lines.
  • Demonstrated excellent selectivity and on-target action.
  • CCT400028 showed improved stability against hydrolysis.

Abstract

Proteolysis TArgeting Chimeras (PROTACs) can be used to target both the catalytic and noncatalytic functions of a protein, which can be particularly beneficial for proteins with important scaffolding functions like Aurora A. However, instability, poor selectivity profiles, and the hook effect often limit the applicability of PROTACs as chemical probes. In this study, we report the development of CCT400028, a second-generation alisertib-derived Aurora A PROTAC. The hook effect was removed through rational optimization of the CRBN-targeting warhead to decrease affinity for cereblon, which, combined with improved stability to hydrolysis, expands the range of concentrations and duration at which maximal degradation can be achieved. Potent Aurora A degradation was shown in three pediatric tumor cell lines, as well as excellent selectivity and on-target mechanism of action. CCT400028 and a matched inactive control analogue fulfill the criteria for a degrader chemical probe for studying Aurora A degradation in vitro.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

O’Hanlon et al. (2026) studied this question.

synapsesocial.com/papers/696719b10a9733890c4ee1bbhttps://doi.org/10.1021/acs.jmedchem.5c03024
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Structural and Physicochemical Features of Oral PROTACs2024 · 70 citations
  2. 2Intramolecular General Base Catalyzed Ester Hydrolysis. The Hydrolysis of 2-Aminobenzoate Esters2002 · 36 citations
  3. 3Aurora kinase A as a rational target for therapy in glioblastoma2010 · 44 citations
  4. 4Targeting N-Myc in neuroblastoma with selective Aurora kinase A degraders2025 · 27 citations
  5. 5Novel, highly potent PROTACs targeting AURORA-A kinase2022 · 31 citations